Literature DB >> 23567429

Cognitive impairment in euthymic older adults with bipolar disorder: a controlled study using cognitive screening tests.

Ivan Aprahamian1, Rodolfo B Ladeira1, Breno S Diniz1, Orestes V Forlenza2, Paula V Nunes1.   

Abstract

BACKGROUND/
OBJECTIVE: Cognitive impairment is a common feature of bipolar disorder (BD), with increased risk of developing dementia in late life. The aim of this study was to investigate the performance on cognitive screening tests in a sample of older adults with BD, as compared to non-BD subjects.
METHODS: 186 older adults (86 with BD and 100 without BD) were included. Patients were stratified according to cognitive performance (normal cognition, mild impairment, and dementia). The comparison group comprised healthy controls; subjects with cognitive impairment but no dementia (CIND); or patients with probable or possible Alzheimer disease (AD). Sixty-five subjects were cognitively unimpaired (35 BD), 65 had CIND (25 BD), and 56 AD (26 BD). In each of these levels of cognitive function, we compared the performance of BD and non-BD subjects on the Mini-Mental State Examination (MMSE), verbal fluency test (VFT), and the Clock Drawing Test (CDT).
RESULTS: Non-demented patients with BD had a slightly worse global cognitive performance as compared with healthy controls and patients with CIND, as shown by lower scores on the MMSE. Similarly, BD patients performed worse on the VFT, both in the normal cognition range and in the dementia range. Finally, demented BD patients had a significantly worse performance on the CDT as compared with patients with dementia due to AD.
CONCLUSION: Older adults with BD perform significantly worse on some cognitive screening tests as compared with those without BD across different levels of cognition.
Copyright © 2014 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; dementia; elderly; screening tests

Mesh:

Year:  2013        PMID: 23567429     DOI: 10.1016/j.jagp.2012.08.013

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  6 in total

Review 1.  A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia.

Authors:  Camila Nascimento; Villela Paula Nunes; Roberta Diehl Rodriguez; Leonel Takada; Cláudia Kimie Suemoto; Lea Tenenholz Grinberg; Ricardo Nitrini; Beny Lafer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-04-20       Impact factor: 5.067

2.  Age as a predictor of cognitive decline in bipolar disorder.

Authors:  Kathryn E Lewandowski; Sarah H Sperry; Mary C Malloy; Brent P Forester
Journal:  Am J Geriatr Psychiatry       Date:  2013-10-06       Impact factor: 4.105

Review 3.  Clinical features, comorbidity, and cognitive impairment in elderly bipolar patients.

Authors:  Ida Vikan Rise; Josep Maria Haro; Bjørn Gjervan
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-17       Impact factor: 2.570

4.  Discrimination between Alzheimer's Disease and Late Onset Bipolar Disorder Using Multivariate Analysis.

Authors:  Ariadna Besga; Itxaso Gonzalez; Enrique Echeburua; Alexandre Savio; Borja Ayerdi; Darya Chyzhyk; Jose L M Madrigal; Juan C Leza; Manuel Graña; Ana Maria Gonzalez-Pinto
Journal:  Front Aging Neurosci       Date:  2015-12-14       Impact factor: 5.750

5.  Abnormal prefrontal brain activation during a verbal fluency task in bipolar disorder patients with psychotic symptoms using multichannel NIRS.

Authors:  Jing-Jing Sun; Xiao-Min Liu; Chen-Yu Shen; Kun Feng; Po-Zi Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2018-11-13       Impact factor: 2.570

6.  White Matter Tract Integrity in Alzheimer's Disease vs. Late Onset Bipolar Disorder and Its Correlation with Systemic Inflammation and Oxidative Stress Biomarkers.

Authors:  Ariadna Besga; Darya Chyzhyk; Itxaso Gonzalez-Ortega; Jon Echeveste; Marina Graña-Lecuona; Manuel Graña; Ana Gonzalez-Pinto
Journal:  Front Aging Neurosci       Date:  2017-06-16       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.